Tobacco Institute
Issue: Next Wave Cigarette Products
Fields
Annotations
- 1. Advocacy Institute Author
- Affiliation:
Advocacy Institute
- Affiliation:
- 2. Smoking Control Advocacy Resou Author
- Affiliation:
Smoking Control Advocacy Resource Center
- Affiliation:
Document Images
?be public healtb avmmunity has aa obligadoa to raise its owa quesboos
abaut Next as wiell ao C2relsea and ErmL ?bereis ample reason to sound
an alarm abait tbis armeatQOp ofproductl'
John Slade, MD.
University of Medicine & Deatistry of New Jersey
I11111l0lUI
a0Y0CaCY iNSTiTUTE
Smoking Control Advocacy Resource Center (SCARC)
AGTION ALERT
August 21, 1989
Michael Pertschuk
David Cohen
Co-Directo+s
Barry R. Rubin
General Counsel
Frieda P. King
Operationa Manager
Zoe Mikva
Director of Dewbpmertt
Phillip Wilbur
Director
Health Advocacy Resource Center
Judy 8utter
Associate Director
Health Advocacy Resource Center
Michele Bloch
Program Officer
Smoking Control
Advocacy Resource Center
Nancy Stetanik
SCARCNet Manay.r
Erta Kflnny 0. Daly
Helen Lichtenstein
MichaN Morris
Administrative Assistants
eoard of oiraetoes
Patricia Bauman
Richard Bol6ng
Marian Wright Edelman
Susan B. Kin9
Leroy Riehie
Joan Shoroy
Linda Tan-Whelan
Fred YWrtheuner
Kenneth Young
1T90 RHODE ISLAND AVENUE. N.W.
SUITE 600
WASHINGNN, DC 20036-3118
202-669-8475
FAX: (202) 659-8461
Lssue: The Nezt Wave of Cigarette Products
uM=~y
In the first half of 1989 U.S. cigarette sales fell at an annual rate
of 4%, doubling the 2% average decline in the earlier part of the 1980's.
In an attempt to reverse, or at least suppress, the decline of the U.S.
market, tobacco companies are introducing "new" products marketed to
imply "safer" smoking. These products offer smokers an "answer" to
health risks such as nicotine addiction (Philip Morris' Next) and
sidestream smoke (RJ Reynolds' Cbelsea and Excxl ).
r.w
Philip Morris has begun test marketing a new "de-nicotined"
cigarette, Next, its latest product designed to entice those in search of a
"safe" and non-addictive cigarette. Withh the acquisition of General Foods,
Philip Morris obtained Sanka brand decaffeinated coffee. They have
drawn the obvious metaphor of the decaffeination of coffee to the
reduction of nicotine in tobacco. Next, however, is = nicotine free; the
nicotine levels (ranging from 0.04 to 0.09 mg) are actually on par with
those of Now and Carlton (0.1 mg). What distinguishes Next is tar levels
of 4-10 mg, closer to those of regular cigarettes than the other two low
nicotine brands (1 mg). Tar is an important component of tobacco
"taste", however it is also the main cause of lung cancer.
Next is Philip Morris' answer to the 1988 Surgeon General's
Report on the Health Consequences of Smoking: Nicotine Addiction that
implicated nicotine as a drug as addictive as heroin. Although Philip
Morris carefully avoids calling attention to the hazards of nicotine, they
frame Next as a new 'choicj" for smokers. Ads announce Next "offers
smokers a choice they never have bad" and "The Next choice is yours".
Cleariy, the implication is that Next will not make smokers addicts like
other smokers. Studies will need to be conducted to determine a Next
smoker's level of nicotine intake. It is unclear whether a Next smoker
would have to inhale it more deeply and for longer periods and thus
intake more tar than a smoker of a higher nicotine brand.
TIMN 311765

A"Smoke Sanka" marketing strategy for Next plays on the link with decaf coffee to
imply safety. Advertisements refer to the 'natural process" of nicotine removal and the phrase
"De-Nic" appears on the cigarette packages. Philip Morris tries to equate the image of smoking
a cigarette with that of drinking a cup of coffee. The coffee lover can enjoy a great many wps
of de-caf coffee without suffering the negative health effects of caffeine; such is = the case
with Next.
In addition to the possibility of market expansion, without an outcry from tobacco
control advocates, Next could be a public relations success. Philip Morris can assume the
posture of a responsible corporation offering a product in demand by consumers. As Philip
Morris spokesman Andrew White says, it is Philip Morris' attempt 'to respond to customers'
preference for a broad range of options.' It is.no surprise that even.by tobacco industry
standards Philip Morris is sparing no expense in the promotion of Nezt in its test markets of
Toledo, Hartford, and Omaha. Spokane is reported to also become a test. market this month.
Full page advertisements are being run in national, city and local publications and billboards and
store promotions abound. What is a surprise, and a cue for tobacco control advocates, is that
the Philip Morris staff is maintaining a"no comment" attitude. Meanwhile, RJR and American
Brands are not silent on Next. RJR is running full page ads for its Now brand which
aggressively attack Next with a message, 'What's Next? Another cigarette with more tar than
Now.'
elsea
RJR's answer to the annoying and offensive smell of sidestream smoke is Chelsea, a
perfumed cigarette. The paper of the Cbelsea cigarette is treated with air freshener which
supposedly solves the problem of smoke pollution. Unfortunately, the perfume does not remove
the over 38 carcinogens known to be in second hand smoke.
Not surprisingly, RJR markets Chelsea to women. It claims to be the first cigarette to
smell good (implicitly admitting that all others smell bad), and implies that a woman who
smokes a cigarette with a"fresh aroma" is more attractive. The marketing of this cigarette
subtlely attracts children as well, with "scratch and sniff" patches in their ads. Although
Chelsea
is not the first perfumed cigarette, it is the first to be marketed heavily by Madison Avenue to
counter public health measures designed to discourage smoking in public places.
F=1
Like Oelsea, Excx1 is made with specially treated paper. However, Fxcrel's gimmick is
to reduce the visibility of sidestream smoke. According to John Slade, 'There is no evidence
that Fxcel actually reduces the harmfulness of tobacco smoke pollution, only its obviousness "
Again according to Slade, Passport, a product similar to Fxce~ was marketed in Canada
but didn't make it out of the 1984 test market. Chemists in the American Health Foundation
demonstrated that its sidestream smoke contained higher concentrations of certain toxic
compounds than traditional cigarettes. ;
RJR is marketing Ercel as the cigarette that "breaks the barrier' between smokers and
nonsmokers. However, by reducing the visibility of sidestream smoke, nonsmokers may have
less of a warning that they are being exposed to the hazardous pollution than with conventional
cigarettes. This deceptive tactic may prove to strengthen the barrier that RJR hopes to destroy.
TIMN 311766

,
Unlike RJR's marketing failure Premier, these three products are all subtle variations of
the familiar agarette. No claims are made about "deaner" smoke. The lessons the tobacco
companies learned from Premier have been applied to the newest products creating a greater
challenge for tobacco control advocates.
mechve
To publicize the consistent tobacco industry strategy of offering unsafe choices disguised
as 'safe' products.
Media Bites
It's not a new product, it's a new marketing strategy.
This is the Next way to make exorbitant profits at the expense of the public health.
Next- Unsafe at'any level.
The Latin motto which appears on the Next packages reads, 'Veni, vidi, vici" (I came, I
saw, I conquered!). A more truthful version might read, "We came, we sold, we caused
cancer!"
Smoking Exce1 is like carrying a concealed weapon.
1 .1 O. .. -,
"It's a beleaguered industry with a beleaguered product. And it's desperately hoping that it has
found a way out."
Wall Street Journal. June 15, 1989
'Philip Morris is engaging in a wink strategy. They won't concede that cigarettes are hazardous
but at the same time they reassure consumers with a wink and a nod that their new noncigarette
cigarette isn't the one that everyone is worried about."
Michael Pertschuk
Wall Street Journal. June 15, 1989
'If the cigarette contains tobacco at all, it will still produce the thousands of chemicals that are
in the tar including the 43 that are known to cause cancer."
Ron Davis, Director of the Office on Smoking and Health
New York Times. May 31, 1989
This takes people who are marginal to the fold - who never smoked or want to cvt back - and
gives them a way to participate in the smoking culture."
Leo Shapiro, Marketing Consultant
New York Times. May 31, 1989
TIMN 311767
I

r
Suggested Actions
1. File a complaint with the Federal Trade Commission. Each of these products is being
marketed with deceptive practices. By using the phrase "de-nic" Philip Morris is
implying that all nicotine has been removed from Next or that the amount of nicotine is
small enough to be safe and non-addictive. From the recent New England Journal of
Medicine article finding that there is no dose response relationship between nicotine and
tar levels and heart disease, it is safe to assume that Next will cause heart disease like
every other conventional cigarette. Both Fxcel and Chelsea lead the consumer to
believe that less visible or perfumed sidestream smoke reduces the danger of the
product. ,
Write to the
Division of Advertising Practices
Federal Trade Commission
600 Pennsylvania Avenue, NW
Washington, DC 20580
Send a carbon copy of your complaint to the new Federal Trade Commission Chairman,
Janet Steiger, who has expressed support for using case-by-case applications of the
Commission's jurisdiction over advertising deemed to be unfair. Urge her to become
active on the tobacco issue.
Send a carbon copy to your elected representatives as well.
2. Write an op-ed or letter to the Editor describing the dangers of these new tobacco
products and the accompanying marketing strategies. Emphasize the need for regulation
of tobacco products. Try to get health professionals and community leaders add to and
sign on to your piece.
TIMN 311768
